(Q54400297)

English

Stability of estrogen receptor status in breast carcinoma: a comparison between primary and metastatic tumors with regard to disease course and intervening systemic therapy.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/20939012

Stability of estrogen receptor status in breast carcinoma: a comparison between primary and metastatic tumors with regard to disease course and intervening systemic therapy. (English)

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/20939012

breast carcinoma

1 reference

based on heuristic

inferred from title

author name string

Yun Gong

1

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/20939012

Eric Yulong Han

2

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/20939012

Ming Guo

3

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/20939012

Lajos Pusztai

4

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/20939012

Nour Sneige

5

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/20939012

language of work or name

0 references

publication date

11 October 2010

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/20939012

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/20939012

117

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/20939012

4

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/20939012

705-713

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/20939012

Human breast cancer: survival from first metastasis. Breast Cancer Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25506

21 January 2018

What is the role of chemotherapy in estrogen receptor-positive, advanced breast cancer?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25506

21 January 2018

The variability of estrogen receptors in metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25506

21 January 2018

Comparison of Estrogen Receptor Levels in Primary and Regional Metastatic Carcinoma of the Breast

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25506

21 January 2018

Variation in receptor status between primary and metastatic breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25506

21 January 2018

Impact of metastatic estrogen receptor and progesterone receptor status on survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25506

21 January 2018

Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25506

21 January 2018

Optimal fixation conditions for immunocytochemical analysis of estrogen receptor in cytologic specimens of breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25506

21 January 2018

The Measurement of Observer Agreement for Categorical Data

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25506

21 January 2018

Involvement of chemokine receptors in breast cancer metastasis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25506

21 January 2018

Oestrogen receptor status of primary breast carcinomas and their metastases. Relation to pattern of spread and survival after recurrence

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25506

21 January 2018

Comparison of HER-2 and hormone receptor expression in primary breast cancers and asynchronous paired metastases: impact on patient management

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25506

21 January 2018

Sequential steroid hormone receptor measurements in primary breast cancer with and without intervening primary chemotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25506

21 January 2018

The effect of neoadjuvant chemotherapy on histologic grade, hormone receptor status, and HER2/neu status in breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25506

21 January 2018

HER2/neu, p53, Ki67, and hormone receptors do not change during neoadjuvant chemotherapy in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25506

21 January 2018

The effect of neoadjuvant chemotherapy on estrogen and progesterone receptor expression and hormone receptor status in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25506

21 January 2018

Measurement of steroid hormone receptors in breast cancer patients on tamoxifen

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25506

21 January 2018

Effect of tamoxifen on Ki67 labelling index in human breast tumours and its relationship to oestrogen and progesterone receptor status.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25506

21 January 2018

Oestrogen receptor: a stable phenotype in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25506

21 January 2018

Cellular effects of tamoxifen in primary breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25506

21 January 2018

Biomarker changes during neoadjuvant anastrozole, tamoxifen, or the combination: influence of hormonal status and HER-2 in breast cancer--a study from the IMPACT trialists

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25506

21 January 2018

The biology of breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25506

21 January 2018

Frequency of oestrogen and progesterone receptor positivity by immunohistochemical analysis in 7016 breast carcinomas: correlation with patient age, assay sensitivity, threshold value, and mammographic screening.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25506

21 January 2018

Commentary: hormone receptor testing in breast cancer: a distress signal from Canada

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25506

21 January 2018

Relationship between quantitative estrogen and progesterone receptor expression and human epidermal growth factor receptor 2 (HER-2) status with recurrence in the Arimidex, Tamoxifen, Alone or in Combination trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25506

21 January 2018

Immunohistochemical evaluation of hormone receptor status for predicting response to endocrine therapy in metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25506

21 January 2018

Immunohistochemistry of estrogen and progesterone receptors reconsidered: experience with 5,993 breast cancers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25506

21 January 2018

Recommendations for Improved Standardization of Immunohistochemistry

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25506

21 January 2018

The value of estrogen and progesterone receptors in the treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25506

7 January 2021

based on heuristic

inferred from DOI database lookup

Changes in multiple or sequential estrogen receptor determinations in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25506

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunohistochemically determined estrogen receptor phenotype remains stable in recurrent and metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25506

7 January 2021

based on heuristic

inferred from DOI database lookup

Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25506

7 January 2021

based on heuristic

inferred from DOI database lookup

Estrogen and progesterone receptor content of primary and secondary breast carcinoma: influence of time and treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25506

7 January 2021

based on heuristic

inferred from DOI database lookup

Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25506

7 January 2021

based on heuristic

inferred from DOI database lookup

Estrogen and progesterone receptor concordance between primary and recurrent breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25506

7 January 2021

based on heuristic

inferred from DOI database lookup

Changes of biological features in breast cancer cells determined by primary chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25506

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitative changes in cytological molecular markers during primary medical treatment of breast cancer: a pilot study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25506

7 January 2021

based on heuristic

inferred from DOI database lookup

Changes of steroid hormone receptor content by chemotherapy and/or endocrine therapy in advanced breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25506

7 January 2021

based on heuristic

inferred from DOI database lookup

Does the oestrogen receptor concentration of a breast cancer change during systemic therapy?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25506

7 January 2021

based on heuristic

inferred from DOI database lookup

Estrogen receptor status: an important variable in predicting response to endocrine therapy in metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25506

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitative analysis of estrogen receptor heterogeneity in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25506

7 January 2021

based on heuristic

inferred from DOI database lookup

Sequential estrogen receptor determinations from primary breast cancer and at relapse: prognostic and therapeutic relevance. The International Breast Cancer Study Group (formerly Ludwig Group)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25506

7 January 2021

based on heuristic

inferred from DOI database lookup

Bimodal frequency distribution of estrogen receptor immunohistochemical staining results in breast cancer: an analysis of 825 cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25506

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.25506

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/20939012

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/20939012

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54400297&oldid=1524788507"